Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04207437 · ClinicalTrials.gov registry record · NA
Daily Hand-Held Vibration Therapy
A NA study of Cancer and Neuropathy, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 3
- Study locations
NCT04207437: Recruiting NA study of Cancer and Neuropathy, sponsored by Indiana University.
NCT04207437 is a NA study of Cancer and Neuropathy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 16 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04207437, a NA study of Cancer and Neuropathy, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this pilot study is to determine the safety and feasibility of a daily 3-minute hand-held vibration therapy intervention to reduce the severity of CIPN in the hands. The investigators hypothesize that daily vibration therapy can reduce the severity of patient's CIPN in their hands and improve CIPN-related quality of life. The hope is that results from this study will provide early data on the feasibility, efficacy, and most importantly, safety, of daily 3-minute hand-held vibration therapy needed to justify future clinical trials examining vibration therapy as a potential option for treating CIPN in the future.
Conditions Studied
Interventions
- DEVICE Vibration therapy
Study Locations (3)
Indiana
- Indiana University Health West - Avon
- Indiana University Melvin & Bren Simon Cancer Center - Indianapolis
- IU Health Joe & Shelly Schwarz Cancer Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-12-06 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT04207437 shows while recruiting
NCT04207437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Vibration therapy is the first listed.
NCT04207437 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04207437 about?
NCT04207437 is a clinical study titled "Daily Hand-Held Vibration Therapy". The purpose of this pilot study is to determine the safety and feasibility of a daily 3-minute hand-held vibration therapy intervention to reduce the severity of CIPN in the hands. The investigators hypothesize that daily vibration therapy can reduce the severity of patient's CIPN in their hands and...
What is the current status of trial NCT04207437?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2021-12-06. Estimated completion is 2026-08.
What conditions does trial NCT04207437 study?
This clinical trial studies the following conditions: Cancer, Neuropathy, Chemotherapeutic Toxicity, Chemotherapeutic Drug - Induced Nephropathy.
What interventions are being tested in trial NCT04207437?
The interventions under investigation include: Vibration therapy (DEVICE).
Who is sponsoring clinical trial NCT04207437?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04207437 being conducted?
This trial has 3 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04207437's enrollment target sits among peer trials
16 581st of 615 higher than 32 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI